Dr. Michael Jude McCormick, MD

Dr. McCormick practices at Sierra Endoscopy Center, LLC - HOPD in Grass Valley, California.

Dr. McCormick's NPI, 1235215302, was assigned on October 31, 2006. Dr. McCormick graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1996. Dr. McCormick holds California license A068844.

Dr. McCormick's primary practice is Sierra Endoscopy Center, LLC - HOPD, at 300 Sierra College Dr, Grass Valley, CA 95945.

Dr. McCormick's primary practice is Sierra Endoscopy Center, LLC - HOPD in Grass Valley, California. Dr. McCormick is also affiliated with Dignity Health - Sierra Nevada Memorial Hospital. The medical group on file is Alpine Allergy & Asthma Associates, Inc. Dmand AI also links Dr. McCormick to 2 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCormick practices, 6 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. McCormick's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. McCormick is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. McCormick's licenses on file in 2 states: California and Iowa.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. McCormick treats.

CMS data shows 30,864 Medicare services from Dr. McCormick across 14 procedure codes in 2024, for 745 Medicare patients. Medicare paid $392,981 for them. Every service was in an office.

CMS counts 745 Medicare patients who saw Dr. McCormick in 2024. The largest group is 65 to 74, with 367 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.78, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCormick's median patient age at 67, with 61% women.

In 2024, Dr. McCormick wrote 2,114 Medicare Part D claims for 446 patients. 50% of them were for generic drugs. CMS names the drug for 1,959 of them, across 24 drugs with 11 or more claims each, at $532,814 in total drug cost. In 2023, CMS named 1,928 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. McCormick for performance year 2024, reported individually. Dr. McCormick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 83 general payments to Dr. McCormick from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $612.

Dmand AI lists 2 awards for Dr. McCormick, most recently CMS Stage 1 EHR in 2013.

Dr. McCormick graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1996. Dr. McCormick is a member of AAAAI.

Dr. McCormick is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.